These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8930435)

  • 1. The future of pharmacoeconomics: bridging science and practice.
    Drummond MF
    Clin Ther; 1996; 18(5):969-78; discussion 968. PubMed ID: 8930435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of pharmacoeconomics: a commentary.
    Langley PC
    Clin Ther; 1997; 19(4):762-9; discussion 760-1. PubMed ID: 9377619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of colleges of pharmacy in meeting the pharmacoeconomic needs of the pharmaceutical industry: a conference report.
    Draugalis JR; Coons SJ
    Clin Ther; 1994; 16(3):523-37; discussion 522. PubMed ID: 7923318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomics: an emerging discipline.
    Letizia C
    Qual Assur; 1995 Mar; 4(1):68-74. PubMed ID: 8520866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
    Lipsy RJ
    Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penny and pound wise: pharmacoeconomics from a governmental perspective.
    van Oostenbruggen MF; Jansen RB; Mur K; Kooijman H
    Pharmacoeconomics; 2005; 23(3):219-26. PubMed ID: 15836004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
    Thwaites R; Townsend RJ
    Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
    Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applied pharmacoeconomics. When can publication be legitimately withheld?
    Yee GC; Hillman AL
    Pharmacoeconomics; 1997 Nov; 12(5):511-6. PubMed ID: 10174317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to improve pharmacoeconomic data generalisability between different countries.
    Li SC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1409-13. PubMed ID: 17661723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The generalisability of pharmacoeconomic studies.
    Mason J
    Pharmacoeconomics; 1997 Jun; 11(6):503-14. PubMed ID: 10168092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature.
    Sanchez LA
    Am J Health Syst Pharm; 1999 Aug; 56(16):1630-8; quiz 1638-40. PubMed ID: 10459385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
    Mullins CD; Wang J
    Pharmacoeconomics; 2002; 20(1):9-21. PubMed ID: 11817989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative review of the pharmacoeconomic guidelines in South Africa.
    Carapinha JL
    J Med Econ; 2017 Jan; 20(1):37-44. PubMed ID: 27564849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The practical impact of pharmacoeconomics on institutional managers.
    Cooke J
    Pharmacoeconomics; 1994 Oct; 6(4):289-97. PubMed ID: 10147466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic research and clinical trials: concepts and issues.
    Bootman JL; Larson LN; McGhan WF; Townsend RJ
    DICP; 1989 Sep; 23(9):693-7. PubMed ID: 2800585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomics and health policy. Current applications and prospects for the future.
    Greenberg PE; Arcelus A; Birnbaum HG; Cremieux PY; LeLorier J; Ouellette P; Slavin MB
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):425-32. PubMed ID: 10662390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.